People, not platforms: the real limit to cell and gene therapy scale-up in Europe

A Miller, E Lombardo, J Kirby et al

16 September 2025

Commentary

Don’t play roulette with your clinical vector candidates: rethinking vector design for successful gene therapy

Alan Griffith

11 September 2025

Commentary

Decentralized patient access: how do we get there?

Becky Cap

06 August 2025

Commentary

History, opportunities and challenges for protecting gene therapies: perspectives from private practice and industry

Jennifer O’Farrell, Damien O'Farrell

28 July 2025

Commentary

Incorporating digitalization in the conceptual design, research and development of plasmid biomanufacturing

D Prazeres, A Azevedo, S Oliveira Duarte et al

29 May 2025

Commentary

Choosing the best path to patients: how to decide between in-house and outsourced iPSC therapy development and manufacturing

Laura Koivusalo, Anni Mörö, Ross Macdonald

11 March 2025

Commentary

CAR-T cells in B-cell mediated autoimmune diseases: do all roads lead to Rome?

Dimitrios Mougiakakos

13 February 2025

Commentary

Personalization in advanced cellular ImmunoTherapeutics: activities in Ireland

Athanasios Mantalaris, Nicki Panoskaltsis, Fiona Killard

13 January 2025

Commentary

Illuminating pathways and balancing precision: maximizing economic value in breast cancer gene therapy through integrated CMC, analytics, and collaboration

Arya Bhushan , Preeti Misra

10 September 2024

Commentary

Impact of pharmacometrics in advancing mRNA therapeutics and vaccines

Husain Attarwala

01 August 2024

Commentary

What are the issues associated with developing gene therapies for rare disease and are the current development models working?

Samir Nuseibeh, Els Henckaerts

20 June 2024

Commentary

Navigating the EU joint clinical assessment process: key considerations for manufacturers of ATMPs and oncology medicines

Clare L Hague

18 June 2024

Commentary

De-risking pluripotent stem cell therapies

Stephen Sullivan, Ricardo Baptista

18 June 2024

Commentary

Combining best practices and analytical reference materials to tackle challenges in AAV manufacturing

Mark Verdecia

03 April 2024

Commentary

Comparative analysis of nucleic acid delivery systems for gene therapy: assessing viral and non-viral approaches with emphasis on extracellular vesicles

Nizar Saad

28 February 2024

Commentary

Unlocking the full potential of human induced pluripotent stem cells from haplo-selected cord blood samples—the how and the why

B Aran, D Morrow, E Rodriguez et al

14 February 2024

Commentary

Building rings with spheres: a cell therapy approach to incontinence

M Gilbert, S Čaputová, D Poli et al

07 December 2023

Commentary

An update on prime editing: recent advances and applications

Karl Petri, Julian Grünewald

23 November 2023

Commentary

Innovation in cryopreservation & cold chain management

Barry Fuller, Roland Fleck, Glyn Stacey

22 November 2023

Commentary

Unravelling immunogenicity induced by Cas9 in gene therapy: a comprehensive commentary of current understanding and implications

Anna Lina Cavallo

08 November 2023

Commentary

A new era in medicine: unraveling the evolution and future of gene therapy

M Tanaka-Wakefield, J Ark, Y Gambhir et al

25 October 2023

Commentary